Close Menu

Derek Lowe talks job news at his blog, In the Pipeline. Apparently a potential Roche takeover has spurred a lot of Genentech employees to start looking elsewhere. "Some other Bay area biotechs are apparently seeing shoals of CVs coming in," he says. If you're looking on the east coast, though, good news is that Merck, EMD-Serono, and the NIH Chemical Genomics Center are all hiring.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.